Some investment advisers are entertaining that possibility, especially in light of Monday's triple-digit loss in the Dow.
VIDEO ON MSN MONEY
Toy companies pay decent dividends and are expected to raise prices this year without hurting sales.
But toys are a funny thing. Even when prices rise, parents still buy them because they want to keep their children happy. When it comes down to it, parents will sacrifice a purchase for themselves instead of giving up that new toy for their children.
The toy industry is a tough business with very slim margins.
In the current volatile environment, it may be better to go for dividends than to try riding out the storm.
By Kate Stalter, MoneyShow.com
Today's low-interest-rate environment has adviser Chris Kichurchak putting clients into high-yield equity funds. In an interview with MoneyShow's Kate Stalter, he discusses three that he likes and explains why he's seeking mainly yield now instead of capital appreciation.
The restaurant chain posted better-than-expected earnings, but foresees headwinds in 2012.
By Zacks Equity Research
Bob Evans Farms Inc. (BOBE) announced third-quarter 2012 earnings of 69 cents per share on Tuesday after the bell, breezing past the Zacks Consensus Estimate of 60 cents per share and the year-ago quarter earnings of 51 cents.
The better-than-expected results were driven by cost-control initiatives of the company and improving sales trend.
Here's a look at a leader in HIV/AIDS treatments and a pioneering play in molecular diagnosis.
Cepheid (CPHD) has a very large idea -- it's aiming to "democratize" molecular diagnostic testing through its revolutionary GeneXpert system.
Gilead Sciences (GILD) is a big biopharmaceutical company with 14 products on the market, including ﬁve medicines for the treatment of HIV/AIDS that accounted for 86% of 2010 revenue.
These small caps that focus on specific software niches have been sporting good price appreciation lately.
By Kate Stalter, MoneyShow.com
Although there was much media fanfare Monday as Apple (AAPL) reached $500, small caps are outpacing their larger cousins' price growth so far in 2012.
The cloud-based business software has been in the spotlight recently, with small caps clearly setting the pace for gains.
After Wednesday's drop, the stock rebounds to make a small afternoon gain.
Apple (AAPL) went back to its pattern of climbing ever higher Thursday, comforting investors who had been watching for a repeat of Wednesday's drop.
After a morning of fingernail biting, Apple shares moved into positive territory in the afternoon and closed at $502.21 -- nearly 1% above Wednesday's $497.67 close.
The day was not an easy one for some investors. "AAPL is giving me an ULCR," one wrote on Twitter.
Ralph Lauren is upgraded to 'buy,' while Deere is downgraded to 'market perform.'
Thursday's noteworthy upgrades include:
The Tiffany network needs to account for its aging viewers and the overall changes in people's media habits.
CBS' (CBS) advertising revenue declined in the fourth quarter and in 2011 despite the network's being home to some of the best and most popular shows on television, including "Big Bang Theory," "Two Broke Girls" and "Person of Interest." How sad is that?
The Tiffany network cited the usual suspects, including lower political advertising sales and lost revenue from the NBA lockout. Advertising revenue fell to $2.51 billion from $2.62 billion in the fourth quarter and to $9 billion from $9.15 billion last year. Fourth-quarter revenue figures missed Wall Street estimates. Net income, however, rose 31% as rising license revenue and cost cutting offset the slowdown in advertising.
CBS needs to address the fact that the network TV audience is shrinking and getting older.
The momentum hounds who bought the stock on its 9-day climb were scared by its last-minute tumble Wednesday, but they need to realize it can rise again soon.
We all saw it, the hideous, horrible reversal in Apple (AAPL) stock Wednesday and the plummet into the close. It transfixed us. Reversed hard. An intraday reversal. The kind of reversal that any rookie chartist would tell you is the beginning of a rollover. The kind of reversal that, immediately, signaled to everyone I know that the run in Apple -- and the stock market, for that matter -- is over. No questions asked. Done. Finished.
Now because of that rollover there are people, for the first time in nine days, who are down on the stock. They have losses. They chased. They top-ticked for the moment, and now they are furious and they are scared and they are looking over their shoulders and of course they are blaming me.
Any business would kill for this problem: a savings account so flush it's making investors antsy.
New CEO Tim Cook hinted as much Tuesday in his address to the Goldman Sachs Technology and Internet Conference. "I'd be the first to admit, we have more cash than we need to run the businesss," said the famously frugal Cook. But Apple will continue to spend its money judiciously, he added. "We are not going to run out and have a toga party."
The global economy looks shaky, but these dividends are sturdy.
In case you hadn't noticed, it's rough out there. Europe still is quite the mess. China, while still growing, is looking a little suspect these days, and growth in much of the rest of the developing world -- particularly in commodity-exporting countries like Brazil -- depends on Chinese growth that might not materialize if present trends continue.
If you're depending purely on growth to meet your investment goals, you might end up being sorely disappointed. Prudent investors instead should turn to something a little more reliable: income.
To overcome patent expirations, Bristol-Myers Squibb is pursing acquisitions.
To overcome patent expirations, the drug firm is actively pursing acquisitions to strengthen its drug pipeline.
Last month, Bristol-Myers Squibb (BMY) announced that it will buy biotech company Inhibitex for $2.5 billion. The deal will give the pharmaceutical giant a beachhead in the rapidly growing market for hepatitis C virus (HCV) treatments, once regulatory and shareholder approvals are received later this year.
But the automaker misses forecasts because of global troubles, and the record earnings may not thrill the still-struggling people of a nation that bailed the company out.
General Motors (GM) earned its highest profit ever last year, a staggering $7.6 billion on revenue of more than $105 billion.
Yay for GM, right? Well, not really.
Unfortunately, Wall Street was already expecting dramatic profits -- and the automaker actually fell short. What's more, sales overseas were very ugly, including at European and South American operations that were in the red. And let's not forget the outrage some taxpayers are feeling after a money-losing bailout of the Detroit automaker that has helped it rake in record profits.
It all adds up to a very sticky situation for this "successful" automaker in 2012.
A trade deal with China offers another reason for investors to take a good look at Canadian equities.
Canadian Prime Minister Stephen Harper didn't just have close encounters with panda bears during his recent official trip to China. He spent a lot of time cozying up to top officials and businessmen and scored a big agreement: Going forward, Canadian companies will be given the same treatment as domestic Chinese enterprises when they do business there.
The agreement comes hard on the heels of tough comments by Harper that ensuring "market security" might mean Canada ramps up its efforts to sell energy products to trading partners other than the U.S. And China is a willing buyer, Chinese Premier Wen Jiabao told Harper during the trip.
The automaker receives $40 million in advance orders just one day after announcing its newest vehicle.
A day after the company revealed the car, it said it received more than $40 million in advance orders. You only need to put down $5,000 to reserve one -- and that amount is fully refundable -- but it does show legitimate enthusiasm for a car that won't be delivered until 2014.
Tesla hasn't even said how much the sports-utility vehicle will cost.
MORE ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
A light news day combined with heavy technicals weighed on the market.
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.
[BRIEFING.COM] The stock market finished the Tuesday session on the defensive after spending the entire day in a steady retreat. The S&P 500 (-0.6%) posted its third consecutive decline, while the small-cap Russell 2000 (-0.9%) slipped behind the broader market during afternoon action.
Equity indices were pressured from the start following some overnight developments that weighed on sentiment. The market tried to overcome the early weakness, but could not stage a sustained rebound, ... More
More Market News
|There’s a problem getting this information right now. Please try again later.|